These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9205746)

  • 21. [Susceptibility of 36 Helicobacter pylori clinical isolates to four first-line antibiotics and virulence factors].
    Díaz-Reganon J; Alarcón T; Domingo D; López-Brea M
    Rev Esp Quimioter; 2006 Mar; 19(1):34-8. PubMed ID: 16688289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial resistance of Helicobacter pylori in Poland: a multicentre study.
    Dzierzanowska-Fangrat K; Rozynek E; Celińska-Cedro D; Jarosz M; Pawłowska J; Szadkowski A; Budzyńska A; Nowak J; Romańczuk W; Prosiecki R; Jóźwiak P; Dzierzanowska D
    Int J Antimicrob Agents; 2005 Sep; 26(3):230-4. PubMed ID: 16122912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the E test and agar dilution method for antimicrobial suceptibility testing of Helicobacter pylori.
    Glupczynski Y; Broutet N; Cantagrel A; Andersen LP; Alarcon T; López-Brea M; Mégraud F
    Eur J Clin Microbiol Infect Dis; 2002 Jul; 21(7):549-52. PubMed ID: 12172749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin--influence on treatment outcome.
    Adamek RJ; Suerbaum S; Pfaffenbach B; Opferkuch W
    Am J Gastroenterol; 1998 Mar; 93(3):386-9. PubMed ID: 9517645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative study of the safety and efficacy of ebrotidine versus ranitidine and placebo in the prevention of piroxicam-induced gastroduodenal lesions.
    Puscas I; Puscas C; Coltau M; Pasca R; Torres J; Márquez M; Herrero E; Fillat O; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):568-72. PubMed ID: 9205767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
    Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
    Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of ebrotidine and ranitidine in the treatment of benign gastric ulcer.
    Gedliczka O; Bobrzynski A; Rembiasz K; Fillat O; Torres J; Herrero E; Márquez M; Camps F; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):560-4. PubMed ID: 9205765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastroprotective properties of ebrotidine. A review.
    Slomiany BL; Piotrowski J; Slomiany A
    Arzneimittelforschung; 1997 Apr; 47(4A):459-67. PubMed ID: 9205744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy.
    Branca G; Spanu T; Cammarota G; Schito AM; Gasbarrini A; Gasbarrini GB; Fadda G
    Int J Antimicrob Agents; 2004 Nov; 24(5):433-8. PubMed ID: 15519473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacteriostatic and bactericidal activity of ranitidine bismuth citrate in Helicobacter pylori clinical isolates.
    Alarcón T; Domingo D; Prieto N; López-Brea M
    Rev Esp Quimioter; 1999 Mar; 12(1):64-8. PubMed ID: 10209056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ebrotidine versus ranitidine in the healing and prevention of relapse of duodenal ulcer. A multicentre, double-blind, parallel, randomized, controlled study.
    Tulassay Z; Döbrönte Z; Farkas I; Juhász L; Simon L; Prónai L; Torres J; Márquez M
    Arzneimittelforschung; 1997 Apr; 47(4A):551-5. PubMed ID: 9205763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of endogenous nitric oxide and sulfhydryl compounds in ebrotidine-induced gastroprotection.
    Palop D; Conejo L; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):468-71. PubMed ID: 9205745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antimicrobial resistance of 36 strains of Helicobacter pylori in adolescents].
    Huang LP; Zhuang ML; Gu CP
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):210-2. PubMed ID: 19292962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of clarithromycin against intracellular Helicobacter pylori.
    Piccolomini R; Di Bonaventura G; Picciani C; Laterza F; Vecchiet J; Neri M
    Antimicrob Agents Chemother; 2001 May; 45(5):1568-71. PubMed ID: 11302831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary resistance of Helicobacter pylori to antimicrobial agents in Polish children.
    Rozynek E; Dzierzanowska-Fangrat K; Celińska-Cedro D; Jóźwiak P; Madaliński K; Dzierzanowska D
    Acta Microbiol Pol; 2002; 51(3):255-63. PubMed ID: 12588100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of ranitidine bismuth citrate, tetracycline and metronidazole with ranitidine bismuth citrate and azithromycin for the eradication of Helicobacter pylori in patients resistant to PPI based triple therapy.
    Altintaş E; Ulu O; Sezgin O; Aydin O; Camdeviren H
    Turk J Gastroenterol; 2004 Jun; 15(2):90-3. PubMed ID: 15334317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
    Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.
    de Boer WA; Haeck PW; Otten MH; Mulder CJ
    Am J Gastroenterol; 1998 Jul; 93(7):1101-7. PubMed ID: 9672338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Elimination of Helicobacter pylori in patients with recurrent abdominal pain with simultaneous administration of ranitidine, bismuth subsalicylate and clarithromycin].
    Ramirez Mayans JA; Zamora Davila E; Cervantes Bustamante R; Mata Rivera N; Oyervides Garcia I; Cuevas S; Zarate Mondragón FE
    Acta Gastroenterol Latinoam; 1996; 26(5):281-3. PubMed ID: 9363265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helicobacter pylori primary resistant strains over 11 years in French children.
    Kalach N; Serhal L; Asmar E; Campeotto F; Bergeret M; Dehecq E; Spyckerelle C; Charkaluk ML; Decoster A; Dupont C; Raymond J
    Diagn Microbiol Infect Dis; 2007 Oct; 59(2):217-22. PubMed ID: 17662555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.